These findings suggest that in addition to genetic alterations such as pathogenic RB1 variants, DNA methylation-regulated genes related to cancer aggressiveness can be involved in the downregulation of tumor suppressor pathways as well as upregulation of oncogenic pathways that contribute to RB tumorigenesis. Here, RB1 is linked to cancer.